Literature DB >> 24742461

Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain.

Monica R P Elmore1, Allison R Najafi1, Maya A Koike1, Nabil N Dagher1, Elizabeth E Spangenberg1, Rachel A Rice1, Masashi Kitazawa2, Bernice Matusow3, Hoa Nguyen3, Brian L West3, Kim N Green4.   

Abstract

The colony-stimulating factor 1 receptor (CSF1R) is a key regulator of myeloid lineage cells. Genetic loss of the CSF1R blocks the normal population of resident microglia in the brain that originates from the yolk sac during early development. However, the role of CSF1R signaling in microglial homeostasis in the adult brain is largely unknown. To this end, we tested the effects of selective CSF1R inhibitors on microglia in adult mice. Surprisingly, extensive treatment results in elimination of ∼99% of all microglia brain-wide, showing that microglia in the adult brain are physiologically dependent upon CSF1R signaling. Mice depleted of microglia show no behavioral or cognitive abnormalities, revealing that microglia are not necessary for these tasks. Finally, we discovered that the microglia-depleted brain completely repopulates with new microglia within 1 week of inhibitor cessation. Microglial repopulation throughout the CNS occurs through proliferation of nestin-positive cells that then differentiate into microglia.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24742461      PMCID: PMC4161285          DOI: 10.1016/j.neuron.2014.02.040

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  45 in total

1.  Generation of microglial cells from mouse embryonic stem cells.

Authors:  Clara Beutner; Kristin Roy; Bettina Linnartz; Isabella Napoli; Harald Neumann
Journal:  Nat Protoc       Date:  2010-08-05       Impact factor: 13.491

2.  Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions.

Authors:  Alexander Mildner; Hauke Schmidt; Mirko Nitsche; Doron Merkler; Uwe-Karsten Hanisch; Matthias Mack; Mathias Heikenwalder; Wolfgang Brück; Josef Priller; Marco Prinz
Journal:  Nat Neurosci       Date:  2007-11-18       Impact factor: 24.884

3.  Presenilin is necessary for efficient proteolysis through the autophagy-lysosome system in a γ-secretase-independent manner.

Authors:  Kara M Neely; Kim N Green; Frank M LaFerla
Journal:  J Neurosci       Date:  2011-02-23       Impact factor: 6.167

4.  Conditional deletion of the colony stimulating factor-1 receptor (c-fms proto-oncogene) in mice.

Authors:  Jia Li; Ken Chen; Liyin Zhu; Jeffrey W Pollard
Journal:  Genesis       Date:  2006-07       Impact factor: 2.487

5.  Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.

Authors:  James G Conway; Brad McDonald; Janet Parham; Barry Keith; David W Rusnak; Eva Shaw; Marilyn Jansen; Peiyuan Lin; Alan Payne; Renae M Crosby; Jennifer H Johnson; Lloyd Frick; Min-Hwa Jasmine Lin; Scott Depee; Sarva Tadepalli; Bart Votta; Ian James; Karen Fuller; Timothy J Chambers; Frederick C Kull; Stanley D Chamberlain; Jeff T Hutchins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-25       Impact factor: 11.205

6.  Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons.

Authors:  Ghazal Banisadr; Romain-Daniel Gosselin; Patricia Mechighel; William Rostène; Patrick Kitabgi; Stéphane Mélik Parsadaniantz
Journal:  J Comp Neurol       Date:  2005-11-14       Impact factor: 3.215

7.  A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.

Authors:  Hiroaki Ohno; Kazuo Kubo; Hideko Murooka; Yoshiko Kobayashi; Tsuyoshi Nishitoba; Masabumi Shibuya; Toshiyuki Yoneda; Toshiyuki Isoe
Journal:  Mol Cancer Ther       Date:  2006-11       Impact factor: 6.261

8.  Discovery of a cytokine and its receptor by functional screening of the extracellular proteome.

Authors:  Haishan Lin; Ernestine Lee; Kevin Hestir; Cindy Leo; Minmei Huang; Elizabeth Bosch; Robert Halenbeck; Ge Wu; Aileen Zhou; Dirk Behrens; Diane Hollenbaugh; Thomas Linnemann; Minmin Qin; Justin Wong; Keting Chu; Stephen K Doberstein; Lewis T Williams
Journal:  Science       Date:  2008-05-09       Impact factor: 47.728

9.  Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice.

Authors:  Noah Saederup; Astrid E Cardona; Kelsey Croft; Makiko Mizutani; Anne C Cotleur; Chia-Lin Tsou; Richard M Ransohoff; Israel F Charo
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

Review 10.  Debris clearance by microglia: an essential link between degeneration and regeneration.

Authors:  H Neumann; M R Kotter; R J M Franklin
Journal:  Brain       Date:  2008-06-20       Impact factor: 13.501

View more
  633 in total

1.  Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge.

Authors:  Diana M Norden; Paige J Trojanowski; Emmanuel Villanueva; Elisa Navarro; Jonathan P Godbout
Journal:  Glia       Date:  2015-10-15       Impact factor: 7.452

2.  Genetic and Stress-Induced Loss of NG2 Glia Triggers Emergence of Depressive-like Behaviors through Reduced Secretion of FGF2.

Authors:  Fikri Birey; Michelle Kloc; Manideep Chavali; Israa Hussein; Michael Wilson; Daniel J Christoffel; Tony Chen; Michael A Frohman; John K Robinson; Scott J Russo; Arianna Maffei; Adan Aguirre
Journal:  Neuron       Date:  2015-11-20       Impact factor: 17.173

Review 3.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

4.  Complement Targets Newborn Retinal Ganglion Cells for Phagocytic Elimination by Microglia.

Authors:  Sarah R Anderson; Jianmin Zhang; Michael R Steele; Cesar O Romero; Amanda G Kautzman; Dorothy P Schafer; Monica L Vetter
Journal:  J Neurosci       Date:  2019-01-15       Impact factor: 6.167

Review 5.  Multitasking Microglia and Alzheimer's Disease: Diversity, Tools and Therapeutic Targets.

Authors:  Alexandra Grubman; Katja M Kanninen; Tarja Malm
Journal:  J Mol Neurosci       Date:  2016-09-22       Impact factor: 3.444

6.  Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function.

Authors:  Martin Valdearcos; Megan M Robblee; Daniel I Benjamin; Daniel K Nomura; Allison W Xu; Suneil K Koliwad
Journal:  Cell Rep       Date:  2014-12-11       Impact factor: 9.423

Review 7.  Bioactive lipids and pathological retinal angiogenesis.

Authors:  Khaled Elmasry; Ahmed S Ibrahim; Samer Abdulmoneim; Mohamed Al-Shabrawey
Journal:  Br J Pharmacol       Date:  2018-11-19       Impact factor: 8.739

Review 8.  Cell Replacement to Reverse Brain Aging: Challenges, Pitfalls, and Opportunities.

Authors:  Jean M Hébert; Jan Vijg
Journal:  Trends Neurosci       Date:  2018-03-13       Impact factor: 13.837

9.  Development of a Chimeric Model to Study and Manipulate Human Microglia In Vivo.

Authors:  Jonathan Hasselmann; Morgan A Coburn; Whitney England; Dario X Figueroa Velez; Sepideh Kiani Shabestari; Christina H Tu; Amanda McQuade; Mahshad Kolahdouzan; Karla Echeverria; Christel Claes; Taylor Nakayama; Ricardo Azevedo; Nicole G Coufal; Claudia Z Han; Brian J Cummings; Hayk Davtyan; Christopher K Glass; Luke M Healy; Sunil P Gandhi; Robert C Spitale; Mathew Blurton-Jones
Journal:  Neuron       Date:  2019-07-30       Impact factor: 17.173

10.  CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.

Authors:  Samantha A Chalmers; Jing Wen; Justine Shum; Jessica Doerner; Leal Herlitz; Chaim Putterman
Journal:  Clin Immunol       Date:  2016-08-26       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.